ATHENA published in NEJM: dronedarone benefits AF patients

The ATHENA trial, originally presented last May at the Heart Rhythm Society meeting, has been published in the New England Journal of Medicine. The trial found that “dronedarone reduced the incidence of hospitalization due to cardiovascular events or death in patients with atrial fibrillation.”
The ATHENA slide set is available on ClinicalTRialResults.Com.


  1. […] Uncategorized Following fast on the heels of the publication of the ATHENA trial in the NEJM (which we reported here), the FDA has announced that it will hold a hearing of the Cardiovascular and Renal Drugs Advisory […]

Speak Your Mind